Literature DB >> 8645848

Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection.

R D Semba1, P G Miotti, J D Chiphangwi, G Liomba, L P Yang, A J Saah, G A Dallabetta, D R Hoover.   

Abstract

The maternal factors that contribute to high mortality rates among infants born to women with human immunodeficiency virus (HIV) are unclear. We followed 474 HIV-infected mothers and their infants in Malawi from pregnancy through the infants' 12th month of life. Of the 474 HIV-infected pregnant women, 300 (63.3%) were deficient in vitamin A (serum level of vitamin A, <1.05 micromol/L). Mean serum vitamin A levels among mothers whose infants died were 0.78 +/- 0.03 micromol/L compared with 1.02 +/- 0.02 micromol/L among mothers whose infants had survived for the first 12 months of life (P <.0001). The overall infant mortality rate was 28.7%. We divided HIV-positive mothers into six groups according to serum vitamin A levels (micromol/L) as follows: group 1, <0.35; group 2, between 0.35 and 0.70; group 3, between 0.70 and 1.05; group 4, between 1.05 and 1.40; group 5, between 1.40 and 1.75; and group 6, >1.75. Infant mortality rates for each group were 93.3%, 41.6%, 23.4%, 18.5%, 17.7%, and 14.2%, respectively (P < .0001). Maternal vitamin A deficiency during HIV infection may contribute to increased infant mortality.

Entities:  

Mesh:

Year:  1995        PMID: 8645848     DOI: 10.1093/clinids/21.4.966

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Do multiple concurrent infections in African children cause irreversible immunological damage?

Authors:  Sarah J Glennie; Moffat Nyirenda; Neil A Williams; Robert S Heyderman
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 2.  Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis.

Authors:  Andrew L Thorne-Lyman; Wafaie W Fawzi
Journal:  Paediatr Perinat Epidemiol       Date:  2012-07       Impact factor: 3.980

3.  Vitamin A levels and human immunodeficiency virus load in injection drug users.

Authors:  R D Semba; H Farzadegan; D Vlahov
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 4.  Leukocyte homing, fate, and function are controlled by retinoic acid.

Authors:  Yanxia Guo; Chrysothemis Brown; Carla Ortiz; Randolph J Noelle
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

5.  The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania.

Authors:  J L Coley; G I Msamanga; M C Fawzi; S Kaaya; E Hertzmark; S Kapiga; D Spiegelman; D Hunter; W W Fawzi
Journal:  BJOG       Date:  2001-11       Impact factor: 6.531

6.  Modeling the effects of different infant feeding strategies on infant survival and mother-to-child transmission of HIV.

Authors:  Jay S Ross; Miriam H Labbok
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

7.  Vitamin content of breast milk from HIV-1-infected mothers before and after flash-heat treatment.

Authors:  Kiersten A Israel-Ballard; Barbara F Abrams; Anna Coutsoudis; Lindiwe N Sibeko; Lynn A Cheryk; Caroline J Chantry
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-01       Impact factor: 3.731

8.  Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.

Authors:  Timothy M Hanley; Heather L B Kiefer; Aletta C Schnitzler; Jennifer E Marcello; Gregory A Viglianti
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Vitamin A deficiency during pregnancy of HIV infected and non-infected women in tropical settings of Northwest Ethiopia.

Authors:  Andargachew Mulu; Afework Kassu; Kahsay Huruy; Birhanemeskel Tegene; Gashaw Yitayaw; Masayo Nakamori; Nguyen Van Nhien; Assegedech Bekele; Yared Wondimhun; Shigeru Yamamoto; Fusao Ota
Journal:  BMC Public Health       Date:  2011-07-15       Impact factor: 3.295

10.  Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.

Authors:  Hong Jiang; Yunden Badralmaa; Jun Yang; Richard Lempicki; Allison Hazen; Ven Natarajan
Journal:  Lipids Health Dis       Date:  2012-07-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.